Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy

NCT07371247 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ENROLLING_BY_INVITATION

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
MRD
ctDNA

Interventions

DRUG: Step-up therapy
DRUG: Standard treatment Routine treatment

Sponsor

The First Affiliated Hospital with Nanjing Medical University